1995
DOI: 10.1016/0021-9150(94)05499-9
|View full text |Cite
|
Sign up to set email alerts
|

Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
69
1

Year Published

1996
1996
2015
2015

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 105 publications
(74 citation statements)
references
References 38 publications
4
69
1
Order By: Relevance
“…Cholesterol, cholesteryl ester, and TG concentrations were determined by comparison to standard curves using Non-polar Lipid Mix-B, Matreya, Inc., Pleasant Gap, PA, USA, C/N 1130. The accumulation of hepatic free cholesterol (FC) and cholesteryl esters was used as a surrogate marker of cumulative cholesterol absorption and its inhibition in mice (Salisbury et al 1995). Data were reported as mg/g liver and mg/liver.…”
Section: Plasma and Hepatic Lipid Measurementsmentioning
confidence: 99%
“…Cholesterol, cholesteryl ester, and TG concentrations were determined by comparison to standard curves using Non-polar Lipid Mix-B, Matreya, Inc., Pleasant Gap, PA, USA, C/N 1130. The accumulation of hepatic free cholesterol (FC) and cholesteryl esters was used as a surrogate marker of cumulative cholesterol absorption and its inhibition in mice (Salisbury et al 1995). Data were reported as mg/g liver and mg/liver.…”
Section: Plasma and Hepatic Lipid Measurementsmentioning
confidence: 99%
“…Hepatic cholesteryl ester (CE) accumulation, previously reported as an indicator of chronic intestinal cholesterol absorption status, 13 Table I). Reducing cholesterol absorption by ezetimibe or through lack of Npc1l1 prevents cholesterol diet-induced accumulation of hepatic cholesteryl esters.…”
Section: Hepatic and Biliary Cholesterol Determinationmentioning
confidence: 99%
“…to be a saturable process that is sensitive to protease treatment (Bhattacharyya and Connor, 1974); (b) potent saponins, such as pamaqueside, are effective in inhibiting cholesterol transport at concentrations below doses required to complex cholesterol in a 1:1 molar ratio, possibly by interfering directly with a putative cholesterol transporter molecule in the intestine (Salisbury et al, 1995;Morehouse et al, 1999); (c) the poor intestinal absorption of closely related plant sterol molecules suggests discrimination in absorption (Salen et al, 1970); (d) patients with sitosterolemia, a rare inherited disorder, lose the ability to discriminate between plant sterols and cholesterol, resulting in the accumulation of sistosterol in plasma and tissues (Bhattacharyya and Connor, 1974), and (e) the heterogeneity of cholesterol absorption efficiency in animal species and humans remains an enigma (Bhattacharyya and Eggen, 1980;Kushwaha et al, 1993;St Clair et al, 1981;Turley et al, 1997;Shwarz et al, 1998), which suggests a genetic component to the transport process.…”
mentioning
confidence: 99%